Down with Reviews

By Steven Wiley Down with Reviews Review articles simply don’t deserve all the citations they receive. Cited discoveries & hypotheses should always refer to the original literature. There has been a proliferation of review articles and review journals over the last decade, and it is easy to see why. Biologists find them useful to keep up with increasingly complex science, and publishers find them an easy way to increase the im

Written bySteven Wiley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

There has been a proliferation of review articles and review journals over the last decade, and it is easy to see why. Biologists find them useful to keep up with increasingly complex science, and publishers find them an easy way to increase the impact factor of journals. Unfortunately, the reasons why review articles are highly cited are mostly unrelated to their educational value. Instead, it seems mostly due to their increasing use as a surrogate for the primary literature.

Many years ago, the privilege of writing review articles was usually reserved for the most senior of scientists, who would describe the most significant findings in their fields from the previous decade. These would appear in specialized publications, such as the Annual Review of Biochemistry. The topics were specialized and were only chosen for review if sufficient progress had been made to justify a conceptual update. I found these types of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies